Effect of c-peptide on cognitive dysfunction in type 1 diabetic rat

ABSTRACT

Diabetes mellitus is a common metabolic disorder that associates with structural and functional changes in central and peripheral nervous system and progressive decline in cognitive abilities. Recent experimental and clinical data suggested that C-peptide replacement during type 1 diabetes exerts beneficial effects on diabetic rats. Determine the effect of intraperitoneal [IP] injection of c-peptide on cognitive dysfunction in type 1 diabetic rats. 24 male Sprague dawly rats [230-300 gr] used for this project divided into 3 groups 1. control group, 2. type 1 diabetic group and 3. Diabetic group that receive C-peptide [25 nmol/kg/daily for 28 day/IP]. Diabetes induced with IV injection of Streptozotocin [60mg/kg]. Twenty one days after onset of diabet, behavioral tests conducted for seven days. In reference memory assessment, the latency of finding platform during four days decline significantly in all groups [P<0.05]. Mean escape time in diabetic group was significantly longer in comparison to other groups [P<0.05] but in comparison to diabetic group with C-peptide group, memory impairement decline significantly [P< 0.05]. During three days of working memory test, the latency required for finding platform decreased significantly [P<0.05] but this time was longer in diabetic group [P<0.05]. C-peptide could improve memory in diabetic group. C-peptide had significant role in control and inhibition of memory disorder progression